Tag: Fosmanogepix phase 3 trial progress
Clinical Phase 3 Study of Fosmanogepix in Candidemia & Invasive Candidiasis
Basilea Pharmaceutica has recently kicked off a clinical phase 3 study with the antifungal drug Fosmanogepix for the treatment of candidemia and invasive candidiasis....